LIMITED-STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED-STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double immunotherapy attack on aggressive lung cancer
Disease control TerminatedThis study is testing whether adding two immunotherapy drugs (monalizumab and durvalumab) to standard chemotherapy helps people with small cell lung cancer live longer without their cancer getting worse. It includes two groups: people with newly diagnosed advanced cancer and peop…
Matched conditions: LIMITED-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Hirva Mamdani • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Global trial aims to boost survival in aggressive lung cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy and radiation treatment helps people with limited-stage small cell lung cancer live longer without their cancer getting worse. It involves over 500 patients wo…
Matched conditions: LIMITED-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC